Evidence map›Paper›PMID 22253733›Full record

ArticlePloS one2012

SARS coronavirus 3b accessory protein modulates transcriptional activity of RUNX1b.

Bhavna Varshney, Sudhakar Agnihothram, Sudhakar Agnihotram, Yee-Joo Tan, Ralph Baric, Sunil K Lal

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Contribution to pathogenesis of accessory proteins of deadly human coronaviruses.Frontiers in cellular and infection microbiology · 2023
    Review
  2. Article
  3. Article
  4. Gene dosage effects of poly(A) track-engineered hypomorphs.Molecular therapy. Nucleic acids · 2021
    Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

  • Erratum issued
    Agnihotram, Sudhakar [corrected to Agnihothram, Sudhakar]
5 · Who and what money

Authors and funding

6 authors at 4 institutions in 4 countries.

Bhavna VarshneyVirology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Sudhakar Agnihothram
Sudhakar Agnihotram
Yee-Joo Tan
Ralph Baric
Sunil K Lal
University of North Carolina at Chapel Hill · USInternational Centre for Genetic Engineering and Biotechnology · INNational Center for Genetic Engineering and Biotechnology · THNational University of Singapore · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe causative agent of severe acute respiratory syndrome, SARS coronavirus (SARS-CoV) genome encodes several unique group specific accessory proteins with unknown functions. Among them, accessory protein 3b (also known as ORF4) was lately identified as one of the viral interferon antagonist. Recently our lab uncovered a new role for 3b in upregulation of AP-1 transcriptional activity and its downstream genes. Thus, we believe that 3b might play an important role in SARS-CoV pathogenesis and therefore is of considerable interest. The current study aims at identifying novel host cellular interactors of the 3b protein. METHODOLOGY/PRINCIPAL

findingsIn this study, using yeast two-hybrid and co-immunoprecipitation techniques, we have identified a host transcription factor RUNX1b (Runt related transcription factor, isoform b) as a novel interacting partner for SARS-CoV 3b protein. Chromatin immunoprecipitaion (ChIP) and reporter gene assays in 3b expressing jurkat cells showed recruitment of 3b on the RUNX1 binding element that led to an increase in RUNX1b transactivation potential on the IL2 promoter. Kinase assay and pharmacological inhibitor treatment implied that 3b also affect RUNX1b transcriptional activity by regulating its ERK dependent phosphorylation levels. Additionally, mRNA levels of MIP-1α, a RUNX1b target gene upregulated in SARS-CoV infected monocyte-derived dendritic cells, were found to be elevated in 3b expressing U937 monocyte cells. CONCLUSIONS/SIGNIFICANCE: These results unveil a novel interaction of SARS-CoV 3b with the host factor, RUNX1b, and speculate its physiological relevance in upregulating cytokines and chemokine levels in state of SARS virus infection.

Indexed as

Transcription, GeneticAnimalsBinding SitesCell LineCell NucleusChemokine CCL3Core Binding Factor Alpha 2 SubunitEnzyme ActivationExtracellular Signal-Regulated MAP KinasesHumansInterleukin-2MicePhosphorylationPromoter Regions, GeneticProtein BindingRNA, MessengerChemokine CCL3Core Binding Factor Alpha 2 SubunitExtracellular Signal-Regulated MAP Kinasesglycoprotein 3b, coronavirusInterleukin-2RNA, MessengerRUNX1 protein, humanViral Nonstructural ProteinsViral Regulatory and Accessory Proteins

Identifiers

PMID22253733
PMCPMC3257236
OpenAlexW2002977421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.